Teriparatide (PTH 1-34) studies: 484 papers with results
Page 7 of 10
- Strong effect of PTH (1-34) on regenerating bone: a time sequence study in rats.
Skripitz R · Acta orthopaedica Scandinavica · 2000
Animal study (in vivo) · rat · 7 results
- PTH (1-34), but not strontium ranelate counteract loss of trabecular thickness and bone strength in disuse osteopenic rats.
Brüel A · Bone · 2013
Animal study (in vivo) · rat · 5 results
- Teriparatide and Abaloparatide Have a Similar Effect on Bone in Mice.
Brent MB · Frontiers in endocrinology · 2021
Animal study (in vivo) · mouse · 16 results
- Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.
Ersan N · Dento maxillo facial radiology · 2014
Animal study (in vivo) · rat · 6 results
- The effects of combination of alendronate and human parathyroid hormone(1-34) on bone strength are synergistic in the lumbar vertebra and additive in the femur of C57BL/6J mice.
Johnston S · Endocrinology · 2007
Animal study (in vivo) · mouse · 12 results
- Intermittently administered parathyroid hormone [1-34] promotes tendon-bone healing in a rat model.
Bi F · International journal of molecular sciences · 2014
Animal study (in vivo) · rat · 7 results
- Effect of intermittent PTH (1-34) on posterolateral spinal fusion with iliac crest bone graft in an ovariectomized rat model.
Qiu Z · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2013
Animal study (in vivo) · rat · 6 results
- Intermittent administration of teriparatide enhances graft bone healing and accelerates spinal fusion in rats with glucocorticoid-induced osteoporosis.
Sugiura T · The spine journal : official journal of the North American Spine Society · 2015
Animal study (in vivo) · rat · 4 results
- Increased cortical porosity is associated with daily, not weekly, administration of equivalent doses of teriparatide.
Zebaze R · Bone · 2017
Animal study (in vivo) · new zealand white rabbit · 11 results
- Enhancement of graft bone healing by intermittent administration of human parathyroid hormone (1-34) in a rat spinal arthrodesis model.
Abe Y · Bone · 2007
Animal study (in vivo) · rat · 12 results
- Lack of bone neoplasms and persistence of bone efficacy in cynomolgus macaques after long-term treatment with teriparatide [rhPTH(1-34)].
Vahle JL · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2008
Animal study (in vivo) · cynomolgus monkey · 13 results
- Parathyroid hormone [1-34] improves articular cartilage surface architecture and integration and subchondral bone reconstitution in osteochondral defects in vivo.
Orth P · Osteoarthritis and cartilage · 2013
Animal study (in vivo) · rabbit · 11 results
- Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures.
Andreassen TT · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 1999
Animal study (in vivo) · rat · 14 results
- Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34).
Alkhiary YM · The Journal of bone and joint surgery. American volume · 2005
Animal study (in vivo) · rat · 19 results
- Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34).
Nakajima A · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2002
Animal study (in vivo) · rat · 11 results
- Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34.
Miao D · The Journal of clinical investigation · 2005
Animal study (in vivo) · mus musculus · 2 results
- Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys.
Burr DB · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2001
Animal study (in vivo) · cynomolgus monkey · 9 results
- Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure.
Frolik CA · Bone · 2003
Animal study (in vivo) · rat · 10 results
- Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats.
Hock JM · Endocrinology · 1988
Animal study (in vivo) · rat · 11 results
- Mechanical loading enhances the anabolic effects of intermittent parathyroid hormone (1-34) on trabecular and cortical bone in mice.
Sugiyama T · Bone · 2008
Animal study (in vivo) · mouse · 10 results
- Teriparatide as a chondroregenerative therapy for injury-induced osteoarthritis.
Sampson ER · Science translational medicine · 2011
Animal study (in vivo) · mouse · 8 results
- Teriparatide (human parathyroid hormone (1-34)) inhibits osteogenic vascular calcification in diabetic low density lipoprotein receptor-deficient mice.
Shao JS · The Journal of biological chemistry · 2003
Animal study (in vivo) · mouse · 14 results
- Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats.
Liu CC · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 1990
Animal study (in vivo) · rat · 9 results
- Human parathyroid hormone 1-34 reverses bone loss in ovariectomized mice.
Alexander JM · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2001
Animal study (in vivo) · mouse · 10 results
- Comparison of the effects of intermittent and continuous administration of human parathyroid hormone(1-34) on rat bone.
Uzawa T · Bone · 1995
Animal study (in vivo) · rat · 14 results
- Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing.
Nakazawa T · Bone · 2005
Animal study (in vivo) · rattus norvegicus · 11 results
- Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity.
Sato M · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2004
Animal study (in vivo) · monkey · 26 results
- Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora.
Komatsubara S · Bone · 2005
Animal study (in vivo) · rat · 6 results
- Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis).
Jerome CP · Bone · 2001
Animal study (in vivo) · macaca fascicularis · 10 results
- The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate--is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system?
Delmas PD · Bone · 1995
Animal study (in vivo) · sheep · 7 results
- Human parathyroid hormone (1-34) and (1-84) increase the mechanical strength and thickness of cortical bone in rats.
Ejersted C · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 1993
Animal study (in vivo) · rat · 16 results
- OPG and PTH-(1-34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats.
Kostenuik PJ · Endocrinology · 2001
Animal study (in vivo) · rat · 8 results
- Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
Stewart AF · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2000
Animal study (in vivo) · rat · 3 results
- Simultaneous incorporation of PTH(1-34) and nano-hydroxyapatite into Chitosan/Alginate Hydrogels for efficient bone regeneration.
Zou Z · Bioactive materials · 2021
Animal study (in vivo) · rat · 7 results
- Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum.
Oxlund H · Calcified tissue international · 1993
Animal study (in vivo) · rat · 28 results
- Comparison of bone formation responses to parathyroid hormone(1-34), (1-31), and (2-34) in mice.
Mohan S · Bone · 2000
Animal study (in vivo) · mouse · 18 results
- New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats.
Ma YL · Endocrinology · 2003
Animal study (in vivo) · rat · 13 results
- Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1-34).
Jolette J · Regulatory toxicology and pharmacology : RTP · 2017
Animal study (in vivo) · rat · 13 results
- Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1-34).
Kneissel M · Bone · 2001
Animal study (in vivo) · rat · 12 results
- Effect of intermittent parathyroid hormone (1-34) treatment on the bone response after placement of titanium implants into the tibia of ovariectomized rats.
Shirota T · Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons · 2003
Animal study (in vivo) · rat · 1 result
- Strontium ranelate enhances callus strength more than PTH 1-34 in an osteoporotic rat model of fracture healing.
Habermann B · Calcified tissue international · 2010
Animal study (in vivo) · rat · 4 results
- Teriparatide (1-34 human PTH) regulation of osterix during fracture repair.
Kaback LA · Journal of cellular biochemistry · 2008
Animal study (in vivo) · mouse · 5 results
- Comparison of the anabolic effects of synthetic parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34 on bone in rats.
Hock JM · Endocrinology · 1989
Animal study (in vivo) · rat · 11 results
- Osteosarcoma in Sprague-Dawley rats after long-term treatment with teriparatide (human parathyroid hormone (1-34)).
Watanabe A · The Journal of toxicological sciences · 2012
Animal study (in vivo) · rat · 4 results
- Anabolic actions of PTH (1-34): use of a novel tissue engineering model to investigate temporal effects on bone.
Pettway GJ · Bone · 2005
Animal study (in vivo) · mouse · 10 results
- Intermittent parathyroid hormone (1-34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats.
Seebach C · Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2004
Animal study (in vivo) · rattus norvegicus · 11 results
- Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits.
Mashiba T · Bone · 2001
Animal study (in vivo) · rabbit · 5 results
- Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys.
Brommage R · The Journal of clinical endocrinology and metabolism · 1999
Animal study (in vivo) · macaca fascicularis · 9 results
- Parathyroid hormone(1-34) and its analogs differentially modulate osteoblastic Rankl expression via PKA/SIK2/SIK3 and PP1/PP2A-CRTC3 signaling.
Ricarte FR · The Journal of biological chemistry · 2018
Animal study (in vivo) · 22 results
- Changes in the contents of enzymatic immature, mature, and non-enzymatic senescent cross-links of collagen after once-weekly treatment with human parathyroid hormone (1-34) for 18 months contribute to improvement of bone strength in ovariectomized monkeys.
Saito M · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2011
Animal study (in vivo) · cynomolgus monkeys · 10 results